CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if ...
Brands That Matter panel to examine Purdue-led pharmaceutical transformations ...
California made a big bet on producing its own insulin. There’s no ‘date certain’ for delivery
California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback